CEACAM5 and cholangiocarcinoma: Serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are commonly used when CCA is suspected but their sensitivity and specificity are widely variable [11]–[13] and, as a result, there is an urgent need for new noninvasive biomarkers.